Just days after an upbeat R&D event, Neurocrine Biosciences has found itself having to report a phase 3 failure. | Neurocrine’s Ingrezza, approved to treat certain uncontrolled movements, failed to ...

Shares of Praxis Precision Medicines ( PRAX +13.25%) leaped on Monday after the clinical-stage biopharmaceutical company ...

Praxis Precision Medicines Inc (NASDAQ: PRAX) stock rose after FDA granted BTD for ulixacaltamide to treat essential tremor.

Rosario Olmos spent this Christmas without one of her greatest gifts. Her 19-year-old daughter had gone missing the day before just outside San Antonio, Texas.

The Breakthrough Therapy Designation was granted based on the positive topline results from the Essential3 Phase 3 program in ...

Scroll through social media and you'd be forgiven for thinking saunas and cold plunges are close to a miracle cure, boosting ...

The Securities and Exchange Commission has named Globe Telecom Inc.’s chief sustainability and corporate communications ...

Even one of the most disruptive international events since World War II — the COVID-19 pandemic — appeared to have little ...

Three ski mountaineers have died after being caught in an avalanche near Panticosa, Huesca, in the Aragonese Pyrenees, one of ...

New Year's holidays, with their gastronomic abundance, traditionally become a challenge for digestion and figure, but there ...

Have you considered the long-term benefits of single tooth dental implants for oral health restoration? Discover why they ...

IF YOU'VE ever watched your cat stare intensely out the window at a bird, making that peculiar "ek-ek-ek" chattering sound ...